Dehydroepiandrosterone and GDF-15 for follow-up of patients with pulmonary arterial hypertension
V. Foris (Graz, Austria), C. Mutgan (Graz, Austria), A. Borenich (Graz, Austria), G. Kovacs (Graz, Austria), P. Douschan (Graz, Austria), T. Sassmannn (Graz, Austria), K. Zeder (Graz, Austria), A. Olschewski (Graz, Austria), G. Kwapiszewska (Graz, Austria), H. Olschewski (Graz, Austria)
Source: Virtual Congress 2021 – All about pulmonary arterial hypertension
Session: All about pulmonary arterial hypertension
Session type: Oral Presentation
Number: 144
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Foris (Graz, Austria), C. Mutgan (Graz, Austria), A. Borenich (Graz, Austria), G. Kovacs (Graz, Austria), P. Douschan (Graz, Austria), T. Sassmannn (Graz, Austria), K. Zeder (Graz, Austria), A. Olschewski (Graz, Austria), G. Kwapiszewska (Graz, Austria), H. Olschewski (Graz, Austria). Dehydroepiandrosterone and GDF-15 for follow-up of patients with pulmonary arterial hypertension. 144
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: